Biophan and Siemens to Design New MRI Systems

Biophan Technologies, Inc. (Rochester, NY, USA), a developer of next-generation medical technology, has announced a declaration of intent to enter into negotiations for a strategic research collaboration between Siemens' Medical Solutions' (Erlangen, Germany) Magnetic Resonance Imaging (MRI) Division in Europe and Biophan Europe GmbH, designed to provide new systems in the growing field of interventional MRI medicine and MRI-assisted minimally invasive surgeries.

The anticipated collaboration is planned to further develop and commercialize potentially complementary MRI technologies. Biophan Europe is emerging as a major force of innovative systems to enable effective MRI visualization of implanted medical devices, including heart valves, coronary and peripheral stents and vena cava filters.

Siemens' MRI Division, in turn, has developed a new MRI scanning technology with aperture configurations that could be highly complementary to Biophan's research and development program in this area, according to Dr. Michael Friebe, CEO of Biophan-Europe.

"Siemens' new 1.5 Tesla open bore MR Magnetom Espree with Tim [total imaging matrix] technology, with its wide aperture, will be ideally suited for MRI-related interventional procedures, combined with our own expertise under chief technology officer Dr. Andreas Melzer in positioning and interventional support hardware, form a solid foundation for partnership and further joint development of medically needed MRI scanning solutions,” Dr. Friebe said.




Related Links:
Biophan Technologies
Siemens Medical Solutions